Literature DB >> 11136288

Rifabutin-based Helicobacter pylori eradication 'rescue therapy'.

F Canducci, V Ojetti, P Pola, G Gasbarrini, A Gasbarrini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11136288     DOI： 10.1046/j.1365-2036.2001.00909.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  15 in total

1.  Second-line rescue therapy of helicobacter pylori infection.

Authors:  Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

2.  Efficacy and tolerability of rifampicin-based rescue therapy for Helicobacter pylori eradication failure in peptic ulcer disease.

Authors:  Vineet Ahuja; Vikram Bhatia; S Dattagupta; Akshay Raizada; Mahesh Prakash Sharma
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 3.  "Rescue" regimens after Helicobacter pylori treatment failure.

Authors:  Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 4.  Third-line rescue therapy for Helicobacter pylori infection.

Authors:  Rossella Cianci; Massimo Montalto; Franco Pandolfi; Giovan-Battista Gasbarrini; Giovanni Cammarota
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

5.  Treatment of Helicobacter pylori Eradication Failures.

Authors:  Javier P. Gisbert; José María Pajares
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

6.  [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].

Authors:  Javier P Gisbert; Xavier Calvet; Juan Ferrándiz; Juan Mascort; Pablo Alonso-Coello; Mercè Marzo
Journal:  Aten Primaria       Date:  2012-10-01       Impact factor: 1.137

Review 7.  Basis for the management of drug-resistant Helicobacter pylori infection.

Authors:  Francis Mégraud
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Dual therapy trial using esomeprazole and amoxicillin as third-line rescue therapy for Helicobacter pylori infection.

Authors:  Hyun Kyung Park; Dong Ho Lee; Seungchul Suh; Pyoung Ju Seo; Nayoung Kim; Sook-Hyang Jeong; Jin-Wook Kim; Jin-Hyeok Hwang; Young Soo Park; Sang Hyub Lee; Cheol Min Shin
Journal:  Clin Endosc       Date:  2011-09-30

9.  Helicobacter pylori eradication therapy: A review of current trends.

Authors:  A B Olokoba; O A Obateru; M O Bojuwoye
Journal:  Niger Med J       Date:  2013-01

10.  Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.

Authors:  José M Navarro-Jarabo; Nuria Fernández; Francisca L Sousa; Encarnación Cabrera; Manuel Castro; Luz M Ramírez; Robin Rivera; Esther Ubiña; Francisco Vera; Isabel Méndez; Francisco Rivas-Ruiz; José L Moreno; Emilio Perea-Milla
Journal:  BMC Gastroenterol       Date:  2007-07-25       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.